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Effects of Novel Aging-Delaying Plant Extracts on the Lipid Composition of the Yeast 
Saccharomyces Cerevisiae  
 
Mélissa McAuley, M.Sc. 
 
A collaboration between the Titorenko laboratory and Idunn Technologies Inc. has led to a recent 
discovery of 14 plant extracts that delay the chronological mode of aging in the budding yeast 
Saccharomyces cerevisiae. Age-related changes in the abundance of lipid droplets, a site for the 
deposition and lipolytic degradation of the neutral lipids triacylglycerols and steryl esters, are 
known to play essential roles in defining yeast longevity. Therefore, one objective of my thesis 
was to investigate how each of the 14 aging-delaying plant extracts influences the number and size 
of lipid droplets at different stages of yeast chronological aging. I found that 8 of 14 plant extracts 
delay yeast chronological aging not because they alter the number of droplets or change their size. 
Because the number and size of lipid droplets are known to be defined by the relative rates of 
neutral lipid synthesis in the endoplasmic reticulum, neutral lipid deposition in lipid droplets, 
neutral lipid lipolytic degradation in lipid droplets, fusion of lipid droplets and fragmentation of 
lipid droplets, I concluded that the aging-delaying effects of these 8 plant extracts in yeast are 
unlikely to be caused by changes in the relative rates of the above cellular processes. I also found 
that 6 of 14 aging-delaying plant extracts cause changes in the number or size of lipid droplets 
only on one or two (out of four) days of cell collection, each corresponding to different stages of 
the aging process. These findings suggest that such changes in lipid droplets abundance may (or 
may not) play essential roles in the ability of some (or all) of these 6 plant extracts to delay yeast 
chronological aging. To address this, further experiments are required. Because the synthesis, 
iv 
 
storage and degradation of neutral lipids are integrated into metabolic pathways for other lipid 
classes, I then used a combination of liquid chromatography and mass spectrometry to examine 
how 2 of the aging-delaying plant extracts that increase the size of lipid droplets without affecting 
their number affect the intracellular concentrations of several classes of lipids in chronologically 
aging S. cerevisiae. I found that these 2 aging-delaying plant extracts exhibit different and 
statistically significant effects on the concentrations of phosphatidylinositol phospholipids, 
triacylglycerols and free fatty acids. I therefore concluded that there may be 2 different ways of 
remodeling lipid metabolism in response to 2 different aging-delaying plant extracts. Future 
studies will test if such specific remodeling of lipid metabolism plays a causal role in the ability 
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1.1 Aging and Age-Related Diseases 
 Aging, known as the progressive decline in fitness of an organism over time, is a 
process affecting us all. It is estimated that by 2026, one in five Canadians will be a senior 
citizen (Canadian Institutes of Health Research 2010). It has also been reported that the 
greatest factor for most life-threatening disorders today is age itself (World Health 
Organization 2017). This unnerving fact has driven more scientists to this field of research 
over recent years, especially because the molecular mechanisms through which aging 
occurs appeared to be linked to such devastating age-related diseases as arthritis, diabetes, 
sarcopenia, stroke, cancer, cardiovascular diseases and neurodegenerative diseases 
(including Parkinson's, Alzheimer's and Huntington's diseases) (De Cabo et al. 2014).  The 
following nine age-related pathologies are currently known as hallmarks of aging in 
humans and other evolutionarily distant eukaryotic organisms: 1) genomic instability, 2) 
telomere attrition, 3) epigenetic alterations, 4) loss of proteostasis, 5) deregulated nutrient 
sensing, 6) mitochondrial dysfunction, 7) cellular senescence, 8) stem cell exhaustion, and 
9) altered intercellular communication (Figure 1.1) (Lopez-Otin et al. 2013).  Because 
cellular processes underlying organismal aging have been conserved in the evolution, our 
knowledge of these hallmarks can facilitate the development of certain dietary and 
chemical interventions capable of delaying the age-related onset of some (or all) of these 

















Figure 1.1. The 9 hallmarks of aging: genomic instability, telomere attrition, 
epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial 
dysfunction, cellular senescence, stem cell exhaustion, and altered intracellular 
communication. 
 
1.2 Some Dietary and Natural Chemical Interventions Can Delay Aging 
Because They Target Certain Nutrient-Sensing Signaling Pathways  
Our fascination with the possibility of living longer has inspired scientists to 
investigate if the onset and/or progression of the process of biological aging can be delayed 
by certain dietary interventions or natural chemical compounds produced by microbes, 
plants or animals. The most effective aging-delaying dietary and chemical interventions 
that are presently known target certain nutrient-sensing signaling pathways, mitochondrial 
functionality, autophagic degradation and cellular proteostasis (Figure 1.2) (De Cabo et al. 
Lopez-Otin et al. (2013) The Hallmarks of Aging. Cell.
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2014). Several dietary and caloric restriction regimens are known as the most potent ways 
of longevity extension in organisms ranging from the budding yeast S. cerevisiae to the 
long-lived populations of Okinawa, Japan (De Cabo et al. 2014; Brandhorst et al. 2015). 
All these dietary and caloric restriction regimens change the organismal and intracellular 
nutrient and energy status, thus regulating a network of nutrient-sensing pathways and 
protein kinases that converges on the mechanistic target of rapamycin (mTOR) protein 
complex (Blagosklonny 2009). Likewise, the aging-delaying chemical compound 
rapamycin has been shown to extend longevity in yeast and other lower eukaryotes by 
inhibiting the mTOR function, but also to cause some unwanted side-effects (such as 
diabetes) in mice fed with rapamycin for a prolonged period (Lamming et al. 2012). 
Functioning through two separate complexes, mTORC1 and mTORC2, mTOR is known 
to respond to nutrient availability and changes in growth hormone concentrations (Johnson 
et al. 2013). Because mTOR is a master regulator of cellular growth and metabolism, its 
inhibition in response to dietary/caloric restriction or rapamycin extends longevity by 
increasing stress resistance, promoting mitochondrial respiration, reducing insulin/IGF-1-
like signaling and activating autophagy (Figure 1.2) (Johnson et al. 2013). In addition, the 
longevity-extending effects of such aging-delaying chemical compounds as metformin and 
spermidine are due to their abilities to alter the intracellular energy status and activate 
autophagy (Figure 1.2) (De Cabo et al. 2014). Furthermore, it is believed that the aging-
delaying compound resveratrol interacts with certain SIRT1 and other deacetylases in the 
nucleus to activate transcription of genes required for autophagy activation (Figure 1.2) 
(De Cabo et al. 2014). Moreover, the aging-delaying compound lithocholic bile acid has 
been shown to extend longevity of chronologically aging yeast by changing the lipid 
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composition of mitochondrial membranes and improving mitochondrial functionality 
(Medkour et al. 2017). 
 
Figure 1.2. Caloric restriction (CR) leads to activation of sirtuins promoting 
longevity. CR also inhibits insulin and mTOR pathways, leading to the activation of stress 
resistance and autophagy. Resveratrol, rapamycin, and spermidine all show autophagy-
dependent anti-aging mechanisms both at the nuclear and cytosolic levels. Whether 
resveratrol directly interacts with the sirtuin family member SIRT1 remains controversial. 
Metformin promotes AMPK activity and prevents oxidative damage. Ac, acetyl residue; 
HAT, histone acetyltransferase; AMPK, adenosine monophosphate-activated protein 
kinase; AKT/PKB, protein kinase B.   
 
 
1.3 The Lipid Composition of a Yeast Cell Affects Its Growth, 
Functionality, Survival and Death 
Lipid synthesis and degradation have previously been linked to certain fat-storage 
diseases, such as Gaucher disease and obesity; lipid metabolism is considered one of the 
major factors that influence organismal lifespan and health in evolutionarily distant 
eukaryotes (National Institute of Neurological Disorders and Stroke 2018) (National 
Institutes of Health 2014). The ability of lipids to define organismal lifespan and healthspan 
De Cabo, et al. (2014) The Search for Antiaging Interventions: From Elixirs to Fasting Regimens. Cell. 
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is due to the essential roles of lipids in fat synthesis, energy storage and supply, cell 
signaling, membrane integrity and biogenesis, and cell death (Klug & Daum 2014; 
Schroeder & Brunet 2015).  
The budding yeast S. cerevisiae is a useful model organism for studying the 
metabolism and function of different classes of lipids. Based on the structure and function 
of lipids, these hydrophobic, water-insoluble molecules can be classified into several major 
groups as follows: free fatty acids (FFAs), phospholipids, sterols, sphingolipids and 
nonpolar (i.e. uncharged and therefore also known as neutral) lipids (Klug & Daum 2014).  
FFAs are composed of a carboxylic acid with a hydrocarbon tail having varying 
degrees of (un)saturation (Klug & Daum 2014). S. cerevisiae can acquire FFAs through 
the following three processes: 1) via de novo synthesis; 2) via lipolytic degradation of 
complex lipids, such as phospholipids, sterols, sphingolipids and neutral lipids; and 3) via 
transport of exogenous FFAs into the cell across the plasma membrane (PM) (Tehlivets et 
al. 2007). The composition of FFAs in a yeast cell can be changed in response to changes 
in the nutrient and environmental status of this cell, but under most conditions  the major 
classes of FFAs are palmitoleic acid (C16:1), oleic acid (C18:1), palmitic acid (C16:0) and 
stearic acid (C18:0), whereas the minor classes of FFAs are myristic acid (C14:0) and 
cerotic acid (C26:0) (Tehlivets et al. 2007).  
Furthermore, phospholipids, sphingolipids and sterols are important classes of 
complex lipids that have been found in organellar and cellular membranes; these lipid 
classes play essential roles in preserving membrane integrity, controlling membrane-based 
signaling, modulating membrane fusion and regulating cell death (Klug & Daum 2014). 
Phospholipids are amphipathic lipid molecules having a hydrophobic diacylglycerol (DG) 
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moiety covalently attached to certain hydrophilic head group (which is different for 
different classes of phospholipids). The major classes of phospholipids in S. cerevisiae are 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and 
phosphatidylserine (PS) (Klug & Daum 2014). Sphingolipids have a ceramide backbone 
consisting of a sphingoid long-chain base (LCB) which is covalently linked to a FFA. This 
hydrophobic tail is attached to an inositol-containing molecule which serves as a 
hydrophilic (polar) head group (Klug & Daum 2014). Phytosphingosine (PHS) and 
dihydrosphingosine (DHS) are the only types of LCB found in yeast sphingolipids; in most 
S. cerevisiae sphingolipids, they are covalently linked to an FFA called cerotic acid (C26:0) 
(Klug & Daum 2014). The sterol class of complex lipids in S. cerevisiae is represented by 
ergosterol, which resides mainly in the PM and has been implicated in maintaining the 
integrity of this cellular membrane (Klug & Daum 2014).   
FFAs and ergosterol are known to be toxic if present in concentrations exceeding a 
threshold (Klug & Daum 2014). A potential lipotoxic effect of FFAs and ergosterol can be 
weakened by their conversion into triacylglycerols (TAGs) and ergosteryl esters (EEs) 
(respectively) in the endoplasmic reticulum (ER), and by their subsequent deposition in 
lipid droplets (Klug & Daum 2014). The lipolytic degradation of TAGs and EEs that have 
been deposited in lipid droplets provides bulk quantities of FFAs, phospholipids and 
ergosterol needed for the fast expansion of the cellular surface during rapid growth of a 
eukaryotic cell (Klug & Daum 2014).   
 
1.4 Lipid Droplets (LDs) Are Dynamic Organelles Implicated in Many 
Cellular Processes in Yeast and Multicellular Eukaryotes 
7 
 
LDs are cytoplasmic organelles in which a hydrophobic core of neutral lipids (i.e. 
TAGs and steryl esters or EEs) is surrounded by a phospholipid monolayer in association 
with several membrane proteins (Figure 1.3) (Walther & Farese Jr. 2012). LDs have been 
found in all presently known eukaryotic organisms; it is believed therefore that the ability 
to form LDs is one of the earliest evolutionarily traits of eukaryotic cells (Walther & Farese 
Jr. 2012). The mechanism by which LDs arise in the cytoplasm of a eukaryotic cell is not 
completely understood, but it is believed that they are formed from the ER through budding 











Figure 1.3. Schematic overview of the structure of a lipid droplet. 
 
LDs are very abundant in S. cerevisiae during stationary phase of culturing (Walther 
& Farese Jr. 2012). During exponential growth of a yeast culture, the TAG and EE 
components of LDs undergo intensive lipolysis to provide yeast with FFAs, phospholipids 
Walther et al. (2012) Lipid Droplets and Cellular Lipid Metabolism. Annual Review of Biochemistry. 
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and ergosterol needed for the rapid expansion of the PM(Walther & Farese Jr. 2012). The 
major phospholipids present in the LD monolayer are phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), and phosphatidylinositol (PI) (Walther & Farese Jr. 2012) 
(Penno et al. 2013). 
Although LDs have long been considered only as comparatively static organelles 
that are used for protecting a eukaryotic cell from the lipotoxic effect of excessive 
concentrations of FFAs and steryl esters (EEs in yeast), recent studies have implicated LDs 
in many other vital cellular processes. These cellular processes include the following: 1) 
the G1/S phase transition during cell cycle of S. cerevisiae, when the accelerated lipolysis 
of TAGs in LDs provides FFAs and phospholipids for bud formation (Kurat et al. 2009); 
2) the establishment of contact sites between LDs and peroxisomes for intensifying 
peroxisomal -oxidation of FFAs formed in LDs as products of TAG and EE lipolysis in 
S. cerevisiae (Kohlwein et al. 2013; Barbosa et al. 2015); 3) longevity regulation in the 
nematode Caenorhabditis elegans, by providing neutral lipids as the source of abundant 
quantities of FFAs needed for maintaining the viability of this organism (Wang et al. 2008); 
4) temporal housing of histones prior to their recruitment for nuclear division during 
embryo segmentation in Drosophila (Cermelli et al. 2006); and 5) the regulation of the 
synthesis and secretion of pro- and anti-aging adipokines or anti-aging lipophilic hormones 
by white adipose tissue of mice or by cells in the intestine cells of the nematode C. elegans 
(respectively) (Goldberg et al. 2009a). 
 
1.5 Two Different Mechanisms to Delay Yeast Chronological Aging by 
Differently Altering the Abundance of LDs      
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One of the recently discovered functions of LDs is their essential role in defining 
longevity of chronologically aging S. cerevisiae. After being synthesized in the ER from 
FFAs and diacylglycerols (DAGs), the neutral lipids TAGs are delivered to and then stored 
in LDs (Mitrofanova et al. 2018). The lipolytic degradation of TAGs deposited in LDs 
yields FFAs and DAGs; these two lipid products of TAG lipolysis can be then utilized for 
energy production via peroxisomal β-oxidation of FFAs, the formation of phospholipids 
and sphingolipids for expansion of the PM and organellar membranes, and the synthesis of 
several signaling lipids involved in some signaling pathways (Mitrofanova et al. 2018). A 
growing body of evidence indicates that the rates and efficiencies with which TAGs are 
synthesized from FFAs and DAGs in the ER, delivered to and stored in LDs, and 
lipolytically degraded to FFAs and DAGs in LDs define yeast chronological lifespan 
(Goldberg et al. 2009; Mitrofanova et al. 2018; Arlia-Ciommo et al. 2018; Handee et al. 
2016; Li et al. 2017). As described below, two different mechanisms for delaying yeast 
chronological aging by altering these rates and efficiencies (and, thus, by changing the 
abundance of LDs in yeast cells) have been proposed.  
One of these mechanisms operates in yeast grown under caloric restriction (CR) 
conditions, i.e. in a nutrient-rich medium initially containing 0.2% glucose. Under these 
conditions, yeast cells do not accumulate ethanol (Goldberg et al. 2009; Arlia-Ciommo et 
al. 2018). In contrast, yeast cells grown under non-CR conditions (i.e. in a nutrient-rich 
medium initially containing 2% glucose) accumulate substantial concentrations of ethanol, 
a product of glucose fermentation (Goldberg et al. 2009). The build-up of ethanol in yeast 
under non-CR conditions represses the synthesis of the Fox1, Fox2 and Fox3 proteins; each 
of these proteins is essential for the β-oxidation of FFAs in peroxisomes (Figure 1.4) 
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(Goldberg et al. 2009; Arlia-Ciommo et al. 2018). The resulting inability of peroxisomes 
to oxidize FFAs causes the accumulation of fatty acyl-CoA esters (which serve as substrate 
for peroxisomal β-oxidation of FFAs), in peroxisomes (Figure 1.4) (Goldberg et al. 2009; 
Arlia-Ciommo et al. 2018). The build-up of fatty acyl-CoA esters in peroxisomes instigates 
a negative feedback mechanism that initially slows the lipolysis of TAGs to FFAs and 
DAGs in LDs, then attenuates the transport of TAGs from the ER to LDs, and ultimately 
diminishes the synthesis of TAGs from FFAs and DAGs in the ER (Figure 1.4) (Goldberg 
et al. 2009; Arlia-Ciommo et al. 2018). The action of this negative feedback mechanism in 
yeast grown under non-CR conditions leads to the accumulation of FFAs and DAGs in the 
ER and LDs. Because both FFAs and DAGs accelerate the onset of an age-related form of 
regulated cell death (RCD) called liponecrosis (see next section) (Richard et al. 2014; 
Sheibani et al. 2014), the accumulation of these two lipids shortens yeast chronological 
lifespan under non-CR conditions. In contrast, because neither FFAs nor DAGs accumulate 
in yeast under CR conditions, the above mechanism cannot accelerate the chronological 
mode of aging in S. cerevisiae grown under these conditions of low calorie supply (Figure 





           
Figure 1.4. A mechanism by which an accumulation of ethanol by yeast cells grown 
under non-CR conditions on 2% glucose may shorten their chronological lifespan by 
altering the rates and efficiencies with which TAGs are synthesized from FFAs and DAGs 
in the ER, delivered to and stored in LDs, and lipolytically degraded to FFAs and DAGs 
in LDs (Mitrofanova, et al. 2018). Red arrows next to the names of lipid classes denote 
those of them whose concentrations are increased in non-CR yeast. Inhibition bars 
displayed in red color signify negative feedback loops. Abbreviations: DAGs, 
diacylglycerols; ER, the endoplasmic reticulum; FA-CoA, fatty acyl-CoA esters; LDs, 
lipid droplets; TAGs, triacylglycerols; RCD, regulated cell death. 
 
The other mechanism for delaying yeast chronological aging by altering the rates 
and efficiencies with which TAGs are synthesized from FFAs and DAGs in the ER, 
delivered to and stored in LDs, and lipolytically degraded to FFAs and DAGs in LDs has 
been discovered in yeast grown under non-CR conditions on 2% glucose (Handee et al. 
2016; Li et al. 2017). In this so-called radical sink mechanism, wild-type (WT) yeast 
cells that age chronologically under non-CR conditions accumulate reactive oxygen 
species (ROS) that oxidatively damage the following types of cellular molecules: 1) water-
soluble macromolecules (i.e. DNA, RNA and proteins) and small molecules of metabolites; 
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2) membrane-associated proteins and lipids; and 3) unsaturated FFAs incorporated into 
TAGs that are deposited in LDs (Figure 1.5) (Handee et al. 2016; Li et al. 2017). The 
build-up of such oxidatively damaged water-soluble and membrane-associated molecules 
in WT cells accelerates their chronological aging under non-CR conditions (Figure 1.5) 
(Handee et al. 2016; Li et al. 2017). The radical sink mechanism of aging delay is 
activated under CR-conditions in yeast cells carrying the tgl3Δ, tgl4Δ or tgl3Δtgl4Δ 
mutations (which slow down TAG lipolysis in LDs) and in yeast cells overexpressing the 
Dga1 enzyme of TAG synthesis. All these genetic interventions increase the abundance of 
LDs because they decelerate LD degradation or accelerate LD formation under non-CR 
conditions (Figure 1.5) (Handee et al. 2016; Li et al. 2017). This increases the abundance 
of FFAs (including unsaturated FFAs) that are incorporated into TAGs deposited in LDs. 
Because unsaturated FFAs are very susceptible to oxidative damage, their build-up in LDs 
decreases their concentrations in the PM and organellar membranes thus allowing LDs act 
as a radical sink for concentrating oxidatively damaged unsaturated FFAs. By decreasing 
the concentrations of oxidatively damaged unsaturated FFAs in the PM and cellular 
membranes, the conversion of LDs into the radical sink lowers the extent of oxidative 
damage to lipids and proteins associated with these membranes as well as to water-soluble 
macromolecules and small molecules (Figure 1.5) (Handee et al. 2016; Li et al. 2017). 
Such decline in oxidative damage to various cellular molecules causes a delay of 
chronological aging of yeast cells that carry the tgl3Δ, tgl4Δ or tgl3Δtgl4Δ mutations or 
overexpress Dga1 and grow under non-CR conditions on 2% glucose (Figure 1.5) (Handee 




            
Figure 1.5. A ″radical sink″ mechanism for the delay of chronological aging in 
yeast mutants accumulating excessive amounts of LDs under non-CR conditions. The 
thickness of black arrows is proportional to the extent of oxidative damage to various 
molecules, degree of oxidative damage to the entire cell or efficiency with which 
chronological aging is accelerated. Arrows next to the boxes showing names of affected 
processes denote those of them that are intensified (red arrows) or weakened (blue arrows). 
(Mitrofanova, et al. 2018). Abbreviations: LD, lipid droplets; TAG, triacylglycerols; ROS, 
reactive oxygen species. 
  
1.6 Liponecrosis, an age-related form of regulated cell death (RCD) 
Liponecrotic RCD can be caused by a brief (for 2 h) exposure of yeast to exogenous 
palmitoleic acid (POA), a 16-carbon monounsaturated FFA, or DAGs (Goldberg et al. 
2010; Richard et al. 2014; Sheibani et al. 2014). Because the number of yeast cells 
exhibiting hallmarks of liponecrotic RCD increases with chronological age, whereas cell 
susceptibility to this form of RCD declines with chronological age, liponecrotic RCD is 
thought to be an age-related form of RCD (Goldberg et al. 2010; Richard et al. 2014; 
Sheibani et al. 2014; Arlia-Ciommo et al. 2018). The following mechanism of POA-
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induced liponecrotic RCD has been established (Figure 1.6) (Richard et al. 2014; Sheibani 
et al. 2014). An exposure of yeast cells to exogenous POA allows this monounsaturated 
FFA to be incorporated into POA-containing phospholipids that accumulate in the ER 
membrane, mitochondrial membranes and the PM. The accumulation of POA-containing 
phospholipids in the PM decreases the concentration of phosphatidylethanolamine (PE) in 
its outer leaflet; this causes an increase in the PM permeability for small molecules and 
commits yeast to liponecrotic RCD by allowing an uncontrollable flow of these molecules 
into the cell (Figure 1.6) (Richard et al. 2014; Sheibani et al. 2014). The build-up of 
excessively high concentrations of POA-containing phospholipids in mitochondrial 
membranes deteriorates mitochondrial functionality, thus eliciting the excessive generation 
of ROS in mitochondria (Figure 1.6) (Richard et al. 2014; Sheibani et al. 2014). The 
resulting rise of cellular ROS above a toxic threshold 1) causes an oxidative damage to 
different cellular organelles, which leads to their excessive autophagic degradation; and 2) 
elicits an excessive oxidative damage to many cytosolic proteins, which impairs cellular 
proteostasis. These two processes also contribute to the commitment of yeast to 
liponecrotic RCD (Figure 1.6) (Richard et al. 2014; Sheibani et al. 2014). Yeast cells can 
use the following four processes to adapt to the cellular stress imposed by POA, thus 
maintaining viability: 1) peroxisomal oxidation of POA, a process that decreases the 
incorporation of POA into phospholipids that accumulate in the ER membrane, 
mitochondrial membranes and the PM; 2) the incorporation of POA into TAGs, a process 
that also decreases the incorporation of POA into phospholipids; 3) a selective degradation 
of dysfunctional mitochondria via the mitophagic pathway of cargo-selective autophagy, a 
process that allows to maintain a healthy population of functional mitochondria required 
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for the incorporation of POA into TAGs; and 4) a metacaspase-dependent degradation of 
damaged, dysfunctional and aggregated cytosolic proteins, a process that allows the cell to 
sustain cellular proteostasis (Figure 1.6) (Richard et al. 2014; Sheibani et al. 2014).                
 
Figure 1.6. A model for a mechanism underlying POA-induced liponecrotic RCD 
in yeast. Activation arrows and inhibition bars denote pro-death processes (displayed in 
red color) or pro-survival processes (displayed in blue color) for POA-induced liponecrotic 
RCD. Abbreviations: ER, the endoplasmic reticulum; PE, phosphatidylethanolamine; PL, 
phospholipids; PM, the plasma membrane; ROS, reactive oxygen species. 
 
 1.7 The Objective of Studies Described in This Thesis  
In collaboration with Idunn Technologies Inc., the Titorenko laboratory has 
recently discovered 14 plant extracts that delay yeast chronological aging. They have been 
given the following names: PE39, PE42, PE47, PE59, PE64, PE68, PE69, PE72, PE75, 
PE77, PE78, PE79, PE81 and PE83. Because age-related changes in the abundance of LDs 
play essential roles in defining the pace of chronological aging in S. cerevisiae, one 
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objective of my thesis was to use live-cell fluorescence microscopy involving BODIPY 
493/503 staining for examining how each of the 14 aging-delaying plant extracts affects 
the number and size of LDs at different consecutive steps of yeast chronological aging. 
Because the synthesis, storage and degradation of neutral lipids are integrated into 
metabolic pathways for other lipid classes, my other objective was to use a combination of 
liquid chromatography and mass spectrometry to examine how 2 of the 14 aging-delaying 
plant extracts affect the intracellular concentrations of several classes of lipids in 


















2 Effects of Aging-Delaying Plant Extracts on the Number and Size of LDs 
 
2.1 Abstract 
Age-related changes in the abundance of lipid droplets, in which the neutral lipids 
triacylglycerols and steryl esters can be stored or lipolytically degraded under different 
conditions, are known to play essential roles in defining yeast longevity. Therefore, the 
objective of studies described in this chapter of my thesis was to examine how each of the 
14 aging-delaying plant extracts discovered by the Titorenko lab affects the number and 
size of lipid droplets at different stages of yeast chronological aging (i.e. on different days 
of cell collection). These extracts have been given the following names: PE26, PE39, PE42, 
PE47, PE59, PE64, PE68, PE69, PE72, PE75, PE77, PE78, PE79, PE81 and PE83. Each 
of these plant extracts was used in a concentration showing the highest aging-delaying 
efficiency. My findings described in this chapter of the thesis indicate that PE69 tends to 
decrease both the number and size of LDs on all days of cell collection. PE68 decreases 
the size of LDs only on day 1 and has no effect on the number of LDs on any day of cell 
collection. PE75 and PE77 increase the size of LDs only on day 2 or day 1 (respectively); 
none of these two plant extracts alters the number of LDs on any day of cell collection. 
PE78 and PE81 decrease or increase (respectively) the number of LDs on day 1 or day 4 
(respectively); none of them influences the size of LDs on any day of cell collection. I also 
found that PE39, PE42, PE47, PE59, PE64, PE72, PE79 and PE83 do not change either the 





2.2 Materials and Methods 
 
Yeast Strains, Growth Conditions and Staining Assays 
The Saccharomyces cerevisiae wild-type strain BY4742 (MAT his31 leu20 
lys20 ura30) from Thermo Scientific/Open Biosystems was used. Grown in a synthetic 
minimal YNB medium (0.67% Yeast Nitrogen Base without amino acids) containing 2% 
(w/v) glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine 
and 20 mg/l uracil, with and without plant extracts. A 20% stock solution of each plant 
extract in ethanol was made on the day of cell inoculation into the growth medium at a 
final concentration of 0.1%, 0.3%, 0.5% and 1.0%. Cells were cultured at 30°C with 
rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask volume/medium volume” 
ratio of 5:1. Cells were imaged every 24 h starting at log phase growth and continuing for 
four consecutive days using BODIPY 493/503.  
Cell culture samples were collected at specific time-points and fractions were 
diluted in dH2O to determine total number of cells per mL of culture using a 
hemocytometer. 10 µL of serial dilutions (1:10 to 1:103) of cells were applied to the 
hemocytometer, where each square is calibrated to hold 0.1 µL. The average of 4 large 
squares was counted and the concentration of cells in the original flask was calculated as 
follows: number of cells per large square × dilution factor × 10 × 10,000 = total number of 
cells per mL of culture. A concentration of 3.5 × 107 cells/mL was used for each culture to 





Chronological Life Span Assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. Another 
fraction of the cell sample was diluted, and serial dilutions of cells were plated in duplicate 
onto YP (1% yeast extract, 2% bacto peptone) plates containing 2% glucose as carbon 
source. After 2 d of incubation at 30oC, the number of colony forming units (CFU) per 
plate was counted. The number of CFU was defined as the number of viable cells in a 
sample. For each culture, the percentage of viable cells was calculated as follows: (number 
of viable cells per ml/total number of cells per ml) × 100. The percentage of viable cells in 
mid-logarithmic phase was set at 100%. 
 
Live Cell Fluorescence Microscopy and LDs Quantification 
BODIPY 493/503 staining for monitoring neutral lipids deposited in LDs was 
performed as follows. Formaldehyde-fixed cells were permeabilized by treatment with 
0.2% Triton X-100 for 6 min and incubated with 10 μM BODIPY 493/503 (Thermo Fisher 
Scientific) in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl for 15 min to label LDs. Live 
imaging was performed on a Leica DM6000B epifluorescence microscope equipped with 
a high-resolution Hamamatsu Orca ER CCD camera using oil immersion and a 100X 
objective. Images were acquired with 20-ms exposures using PerkinElmer Volocity 
software. Image files were exported as TIFFs then opened in ImageJ where counts were 
preformed using the cell counter add-on and cell-to-LD ratios were quantified by a 
computational macro measuring the total cell fluorescent intensity versus LD intensity for 





 Statistical analysis was preformed using Microsoft Excel’s (2017) Analysis 
ToolPack. All data are presented as mean  SD. The p values for comparing the means of 
two groups (using an unpaired t test) were calculated with the help of GraphPad Prism 





















The aging-delaying plant extract PE39 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE39 statistically significantly increases both the mean 
and maximum chronological lifespans (CLSs) of wild-type (WT) cells of S. cerevisiae 
grown in YNB medium containing 2% glucose (Figure 2.3.1).    
 
Figure 2.3.1. 




aging yeast. WT 
cells were grown 
in YNB medium 
initially 
containing 2% 
glucose, in the 
presence of 0.5% 
PE39 or in its 
absence. 
Survival curves, 
and the mean and 
maximum CLSs 
of these cells are 
shown. Data are 
presented as 
means ± SEM (n 




I found that 0.5% PE39 does not have a statistically significant effect on the 
percentage of cells with 1 to 3, 4 to 6, 7 to 9 or > 10 LDs (Figure 2.3.2). Thus, 0.5% PE39 


















































Figure 2.3.2. 0.5% PE39 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE39 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.5% PE39 does not have a statistically significant effect on the 
ratio Total volume of LDs per cell/Total volume of this cell (Figure 2.3.3). Thus, 0.5% 
PE39 does not change the size of LDs in a yeast cell. 
Figure 2.3.3. 0.5% PE39 
does not change the size 
of LDs in a yeast cell.  
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE39 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 







The aging-delaying plant extract PE42 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE42 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 






aging yeast. WT 
cells were 
grown in YNB 
medium initially 
containing 2% 
glucose, in the 
presence of 
0.5% PE42 or in 
its absence. 
Survival curves, 
and the mean 
and maximum 
CLSs of these 
cells are shown. 
Data are 
presented as 
means ± SEM (n 
= 3; *p < 0.05). 
 
 
I found that 0.5% PE42 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) of LDs and to decrease the percentage of cells with high number (i.e. 7 to 9 and 
> 10 LDs) on most days of cell collection (Figure 2.3.5). However, none of these effects 
of PE42 was statistically significant. I therefore concluded that 0.5% PE42 does not change 














































Figure 2.3.5. 0.5% PE42 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE42 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.5% PE42 does not have a statistically significant effect on the 
ratio Total volume of LDs per cell/Total volume of this cell (Figure 2.3.6). I therefore 
concluded that 0.5% PE42 does not change the size of LDs in a yeast cell. 
Figure 2.3.6. 
0.5% PE42 does not 
change the size of LDs in 
a yeast cell.  WT cells 
were grown in YNB 
medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE42 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 







The aging-delaying plant extract PE47 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.3% PE47 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 






aging yeast. WT 
cells were grown 
in YNB medium 
initially 
containing 2% 
glucose, in the 
presence of 0.3% 
PE47 or in its 
absence. Survival 
curves, and the 
mean and 
maximum CLSs 
of these cells are 
shown. Data are 
presented as 
means ± SEM (n 





I found that 0.3% PE47 tends to increase the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) of LDs and to decrease the percentage of cells with high number (i.e. 
7 to 9 and > 10 LDs) on most days of cell collection (Figure 2.3.8). However, none of 
these effects of PE47 was statistically significant. Therefore, 0.3% PE47 does not change 














































Figure 2.3.8. 0.3% PE47 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.3% PE47 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.3% PE47 tends to decrease the ratio Total volume of LDs per 
cell/Total volume of this cell on each day of cell collection (Figure 2.3.9). However, none 
of these effects of PE47 was statistically significant. I therefore concluded that 0.3% PE47 
does not change the size of LDs in a yeast cell. 
Figure 2.3.9. 0.3% PE47 
does not change the size 
of LDs in a yeast cell.  
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.3% PE47 
or in its absence. Cells 
collected on days 1, 2, 3 
and 4 of culturing were 
subjected to BODIPY 
493/503 staining followed 
by live-cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 
cell/Total volume of this 







The aging-delaying plant extract PE59 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.3% PE59 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 







aging yeast. WT 
cells were grown 
in YNB medium 
initially 
containing 2% 
glucose, in the 
presence of 0.3% 
PE59 or in its 
absence. Survival 
curves, and the 
mean and 
maximum CLSs 
of these cells are 
shown. Data are 
presented as 
means ± SEM (n 





I found that 0.3% PE59 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) of LDs on most days of cell collection (Figure 2.3.11). However, this effect of 
PE59 wasn’t statistically significant. Therefore, 0.3% PE59 does not change the number of 
















































Figure 2.3.11. 0.3% PE59 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.3% PE59 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.3% PE59 tends to decrease the ratio Total volume of LDs per 
cell/Total volume of this cell on each day of cell collection (Figure 2.3.12). However, 
none of these effects of PE59 was statistically significant. I therefore concluded that 0.3% 
PE59 does not change the size of LDs in a yeast cell. 
Figure 2.3.12. 0.3% PE59 
does not change the size of 
LDs in a yeast cell.  WT 
cells were grown in YNB 
medium initially containing 
2% glucose, in the presence 
of 0.3% PE59 or in its 
absence. Cells collected on 
days 1, 2, 3 and 4 of 
culturing were subjected to 
BODIPY 493/503 staining 
followed by live-cell 
fluorescence microscopy 
and LDs quantification. The 
ratios Total volume of LDs 
per cell/Total volume of this 







The aging-delaying plant extract PE64 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.1% PE64 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 







aging yeast. WT 
cells were grown 
in YNB medium 
initially 
containing 2% 
glucose, in the 
presence of 0.1% 
PE64 or in its 
absence. Survival 
curves, and the 
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these cells are 
shown. Data are 
presented as 
means ± SEM (n = 




I found that 0.1% PE64 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) and to decrease the percentage of cells with high number (i.e. > 10) of LDs on 
most days of cell collection (Figure 2.3.14). However, none of these effects of PE64 was 









































Figure 2.3.14. 0.1% PE64 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.1% PE64 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.1% PE64 tends to decrease the ratio Total volume of LDs per 
cell/Total volume of this cell during initial 3 days of cell collection (Figure 2.3.15). 
However, none of these effects of PE64 was statistically significant. I therefore concluded 
that 0.1% PE64 does not change the size of LDs in a yeast cell. 
Figure 2.3.15. 0.1% 
PE64 does not change 
the size of LDs in a yeast 
cell.  WT cells were 
grown in YNB medium 
initially containing 2% 
glucose, in the presence of 
0.1% PE64 or in its 
absence. Cells collected 
on days 1, 2, 3 and 4 of 
culturing were subjected 
to BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 






The aging-delaying plant extract PE68 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE68 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 






aging yeast. WT 
cells were grown in 
YNB medium 
initially containing 
2% glucose, in the 
presence of 0.5% 
PE68 or in its 
absence. Survival 
curves, and the 
mean and 
maximum CLSs of 
these cells are 
shown. Data are 
presented as means 







I found that 0.5% PE68 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) and to decrease the percentage of cells with high number (i.e. > 10) of LDs on 
most days of cell collection (Figure 2.3.17). However, none of these effects of PE68 was 












































Figure 2.3.17. 0.5% PE68 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE68 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
 
I also found that 0.5% PE68 statistically significantly decreases the ratio Total 
volume of LDs per cell/Total volume of this cell on the first day of cell collection (Figure 
2.3.18). On three subsequent days of cell collection, 0.5% PE68 tends to decrease the ratio 
Total volume of LDs per cell/Total volume of this cell (Figure 2.3.18). However, none 
of these effects of PE68 was statistically significant. I concluded that 0.5% PE68 
significantly decreases the size of LDs in a yeast cell only on day 1 of culturing, but after 
that does not change the size of LDs in a yeast cell. 
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Figure 2.3.18. 0.5% 
PE68 significantly 
decreases the size of LDs 
in a yeast cell only on day 
1 of culturing, but after 
that does not change the 
size of LDs in a yeast cell. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% PE68 
or in its absence. Cells 
collected on days 1, 2, 3 
and 4 of culturing were 
subjected to BODIPY 
493/503 staining followed 
by live-cell fluorescence 
microscopy and LDs quantification. The ratios Total volume of LDs per cell/Total volume of this cell are 
shown. Data are presented as means ± SD (n = 2; **p < 0.01; ns = not significant). 
 
The aging-delaying plant extract PE69 extends longevity of chronologically aging 
yeast. Indeed, I found that 1% PE69 statistically significantly increases both the mean and 
maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
glucose (Figure 2.3.19). 
 




aging yeast. WT 
cells were grown in 
YNB medium 
initially containing 
2% glucose, in the 
presence of 1% 
PE69 or in its 
absence. Survival 
curves, and the 
mean and 
maximum CLSs of 
these cells are 
shown. Data are 
presented as means 
























In a single experiment conducted so far, I found that 1% PE69 tends to increase the 
percentage of cells with low number (i.e. 1 to 3) and to decrease the percentage of cells 

























Figure 2.3.20. A single experiment conducted so far indicates that 1% PE69 tends to increase the 
percentage of cells with low number and to decrease the percentage of cells with high number of LDs 
on most days of cell collection.  WT cells were grown in YNB medium initially containing 2% glucose, in 
the presence of 1% PE69 or in its absence. Cells collected on days 1, 2, 3 and 4 of culturing were subjected 
to BODIPY 493/503 staining followed by live-cell fluorescence microscopy and LDs quantification. The 
percentages of cells with certain number of LDs/cell are shown. n = 1. 
 
 
In a single experiment conducted so far, I also found that 1% PE69 decreases the 
ratio Total volume of LDs per cell/Total volume of this cell on days 1, 3 and 4 of cell 







Figure 2.3.21. A single 
experiment conducted so 
far indicates that 1% 
PE69 tends to decrease 
the size of LDs in a yeast 
cell on most days of cell 
collection. WT cells were 
grown in YNB medium 
initially containing 2% 
glucose, in the presence of 
1% PE69 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs quantification. The ratios Total volume of LDs per cell/Total volume of this cell are 
shown. n = 1. 
 
The aging-delaying plant extract PE72 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.1% PE72 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 





aging yeast. WT 
cells were grown in 
YNB medium 
initially containing 
2% glucose, in the 
presence of 0.1% 
PE72 or in its 
absence. Survival 
curves, and the 
mean and 
maximum CLSs of 
these cells are 
shown. Data are 
presented as means 























I found that 0.1% PE72 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) and to decrease the percentage of cells with high number (i.e. > 10) of LDs on 
most days of cell collection (Figure 2.3.23). However, none of these effects of PE72 was 

























Figure 2.3.23. 0.1% PE72 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.1% PE72 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
 
I also found that 0.1% PE72 tends to increase the ratio Total volume of LDs per 
cell/Total volume of this cell on most days of culturing (Figure 2.3.24). However, none 
of these effects of PE72 was statistically significant. I concluded that 0.1% PE72 does not 




Figure 2.3.24. 0.1% 
PE72 does not change 
the size of LDs in a yeast 
cell. WT cells were grown 
in YNB medium initially 
containing 2% glucose, in 
the presence of 0.1% 
PE72 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 
cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
The aging-delaying plant extract PE75 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.3% PE75 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
glucose (Figure 2.3.25). 
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I found that 0.3% PE75 tends to increase the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) and to decrease the percentage of cells with high number (i.e. 7 to 9 
and > 10) of LDs on all days of cell collection (Figure 2.3.26). However, none of these 
effects of PE75 was statistically significant. I therefore concluded that 0.3% PE75 does not 























Figure 2.3.26. 0.3% PE75 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.3% PE75 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.3% PE75 statistically significantly increases the ratio Total 
volume of LDs per cell/Total volume of this cell only on day 2 of culturing, tends to 
increase this ratio on day 1 of culturing (but this effect of PE75 is not statistically 
significant), and has no effect on this ratio on days 3 and 4 of culturing (Figure 2.3.27). 
However, none of these effects of PE72 was statistically significant. I concluded that 0.3% 
39 
 
PE75 increases the size of LDs in a yeast cell on day 2 of culturing but has no effect on the 
size of LDs in a yeast cell on other days of culturing.   
Figure 2.3.27. 0.3% 
PE75 increases the size 
of LDs in a yeast cell on 
day 2 of culturing but 
has no effect on the size 
of LDs in a yeast cell on 
other days of culturing. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.3% 
PE75 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-cell fluorescence microscopy and LDs quantification. The ratios Total volume of 
LDs per cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 2; ns = not 
significant). 
 
The aging-delaying plant extract PE77 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE77 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
glucose (Figure 2.3.28). 
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I found that 0.5% PE77 tends to increase the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) and to decrease the percentage of cells with high number (i.e. 7 to 9 
and > 10) of LDs on all days of cell collection (Figure 2.3.29). However, none of these 
effects of PE77 was statistically significant. I therefore concluded that 0.5% PE77 does not 























Figure 2.3.29. 0.5% PE77 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE77 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.5% PE77 statistically significantly increases the ratio Total 
volume of LDs per cell/Total volume of this cell only on day 1 of culturing, and tends to 
increase this ratio on days 2, 3 and 4 of culturing (but this effect of PE77 is not statistically 
significant) (Figure 2.3.30). Thus, 0.5% PE77 increases the size of LDs in a yeast cell on 




Figure 2.3.30. 0.5% 
PE77 increases the size 
of LDs in a yeast cell on 
day 1 of culturing but 
has no effect on the size 
of LDs in a yeast cell on 
other days of culturing. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE77 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence microscopy and LDs quantification. The ratios Total volume of LDs per cell/Total volume 
of this cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
The aging-delaying plant extract PE78 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.3% PE78 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
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I found that 0.3% PE78 tends to increase the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) and to decrease the percentage of cells with high number (i.e. 7 to 9 
and > 10) of LDs on all days of cell collection (Figure 2.3.32). However, only a decrease 
of the percentage of cells with 7 to 9 LDs on day 1 of culturing with 0.3% PE78 was 
statistically significant. I therefore concluded that 0.3% PE78 decreases the number of LDs 
in a yeast cell only on day 1 of culturing but does not change the number of LDs in a yeast 
cell on all other days of culturing. 
 
Figure 2.3.32. 0.3% PE78 decreases the number of LDs in a yeast cell only on day 1 of culturing but 
does not change the number of LDs in a yeast cell on all other days of culturing.  WT cells were grown 
in YNB medium initially containing 2% glucose, in the presence of 0.3% PE78 or in its absence. Cells 
collected on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-
cell fluorescence microscopy and LDs quantification. The percentages of cells with certain number of 
LDs/cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.3% PE78 tends to increase the ratio Total volume of LDs per 
cell/Total volume of this cell on day 1 of culturing, and tends to decrease this ratio on 


















any of the days of culturing was statistically significant. Thus, 0.3% PE78 has no effect on 
the size of LDs in a yeast cell. 
Figure 2.3.33. 0.3% 
PE78 has no effect on the 
size of LDs in a yeast cell. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.3% 
PE78 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 
cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
The aging-delaying plant extract PE79 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE79 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
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I found that 0.5% PE79 tends to increase the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) and to decrease the percentage of cells with high number (i.e. 7 to 9 
and > 10) of LDs on all days of cell collection (Figure 2.3.35). However, none of these 
effects of PE78 was statistically significant. I therefore concluded that 0.5% PE79 does not 
change the number of LDs in a yeast cell. 
 
Figure 2.3.35. 0.5% PE79 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE79 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.5% PE79 tends to increase the ratio Total volume of LDs per 
cell/Total volume of this cell on days 1 and 4 of culturing and tends to decrease this ratio 
on days 2 and 3 of culturing (Figure 2.3.36). However, none of these effects of PE79 on 
any of these days of culturing was statistically significant. I therefore concluded that 0.5% 


















Figure 2.3.36. 0.5% 
PE79 has no effect on the 
size of LDs in a yeast cell. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE79 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 
cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
The aging-delaying plant extract PE81 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.3% PE81 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
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I found that 0.3% PE81 tends to decrease the percentage of cells with low number 
(i.e. 1 to 3 and 4 to 6) and to increase the percentage of cells with high number (i.e. 7 to 9 
and > 10) of LDs on all days of cell collection (Figure 2.3.38). However, only a decrease 
in the percentage of cells with 1 to 3 LDs and an increase in the percentage of cells with 7 
to 9 LDs on the day 4 of culturing were statistically significant. Thus, 0.3% PE81 increases 
the number of LDs in a yeast cell only on day 4 of culturing but does not change the number 
of LDs in a yeast cell on all other days of culturing. 
 
Figure 2.3.38. 0.3% PE81 increases the number of LDs in a yeast cell only on day 4 of culturing but 
does not change the number of LDs in a yeast cell on all other days of culturing.  WT cells were grown 
in YNB medium initially containing 2% glucose, in the presence of 0.3% PE81 or in its absence. Cells 
collected on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-
cell fluorescence microscopy and LDs quantification. The percentages of cells with certain number of 
LDs/cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
I also found that 0.3% PE81 tends to increase the ratio Total volume of LDs per 
cell/Total volume of this cell on all days of culturing (Figure 2.3.39). However, none of 
these effects of PE81 on any of these days of culturing was statistically significant. I 

















Figure 2.3.39. 0.3% 
PE81 has no effect on the 
size of LDs in a yeast cell. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.3% 
PE81 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 
cell/Total volume of this cell are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
The aging-delaying plant extract PE83 extends longevity of chronologically aging 
yeast. Indeed, I found that 0.5% PE83 statistically significantly increases both the mean 
and maximum CLSs of WT cells of S. cerevisiae grown in YNB medium containing 2% 
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I found that 0.5% PE83 tends to increase the percentage of cells with low number 
(i.e. 1 to 3) and to decrease the percentage of cells with high number (i.e. 7 to 9) of LDs on 
all days of cell collection (Figure 2.3.41). However, none of these effects of PE83 on any 
of these days were statistically significant. I therefore concluded that 0.5% PE83 does not 
change the number of LDs in a yeast cell. 
 
 
Figure 2.3.41. 0.5% PE83 does not change the number of LDs in a yeast cell.  WT cells were grown in 
YNB medium initially containing 2% glucose, in the presence of 0.5% PE83 or in its absence. Cells collected 
on days 1, 2, 3 and 4 of culturing were subjected to BODIPY 493/503 staining followed by live-cell 
fluorescence microscopy and LDs quantification. The percentages of cells with certain number of LDs/cell 
are shown. Data are presented as means ± SD (n = 2; ns = not significant). 
 
 
I also found that 0.5% PE83 tends to increase the ratio Total volume of LDs per 
cell/Total volume of this cell on all days of culturing (Figure 2.3.42). However, none of 
these effects of PE83 on any of these days of culturing was statistically significant. I 




















 Figure 2.3.42. 0.5% 
PE83 has no effect on the 
size of LDs in a yeast cell. 
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE83 or in its absence. 
Cells collected on days 1, 
2, 3 and 4 of culturing 
were subjected to 
BODIPY 493/503 
staining followed by live-
cell fluorescence 
microscopy and LDs 
quantification. The ratios 
Total volume of LDs per 























My live-cell fluorescence microscopy analysis of how each of the 14 aging-
delaying plant extracts influences the number and size of LDs revealed the following. PE69 
tends to decrease both the number and size of LDs on all days of cell collection; because 
these effects were observed in a single experiment conducted so far for PE69, the validity 
of this conclusion will be tested by others in additional experiments with PE69. I found 
that PE68 decreases the size of LDs only on day 1 and has no effect on the number of LDs 
on any day of cell collection. Furthermore, PE75 and PE77 increase the size of LDs only 
on day 2 or day 1 (respectively); none of these two plant extracts alters the number of LDs 
on any day of cell collection. Moreover, PE78 and PE81 decrease or increase (respectively) 
the number of LDs on day 1 or day 4 (respectively); none of them influences the size of 
LDs on any day of cell collection. I also found that PE39, PE42, PE47, PE59, PE64, PE72, 
PE79 and PE83 do not change either the number of LDs or their size on any day of cell 
collection. 
These findings indicate that PE39, PE42, PE47, PE59, PE64, PE72, PE79 and PE83 
delay yeast chronological aging not because they alter the number of LDs or change their 
size. The number and size of LDs are known to be defined by the relative rates of neutral 
lipid synthesis in the ER, neutral lipid deposition in LDs, neutral lipid lipolytic degradation 
in LDs, fusion of LDs and fragmentation of LDs (Kohlwein et al., 2013; Walther and 
Farese, 2012). Thus, the aging-delaying effects of PE39, PE42, PE47, PE59, PE64, PE72, 




 My findings that PE68, PE75, PE77, PE78 and PE81 elicits changes in the number 
or size of LDs only on one or two (out of four) days of cell collection suggest that these 
changes may (or may not) play essential roles in the ability of some (or all) of these plant 
extracts to delay yeast chronological aging. To address this, further experiments are 
required. These future experiments may test how single-gene-deletion mutations 
eliminating proteins involved in the above processes influence the following: 1) the 
efficiencies with which PE68, PE75, PE77, PE78 and PE81 extend longevity of 
chronologically aging yeast; and 2) the size and number of LDs at different stages of the 
aging process in the presence of a PE (i.e. on different days of culturing yeast in medium 
supplemented with this PE).  
In a single experiment conducted so far, I demonstrated that PE69 tends to decrease 
both the number and size of LDs on all days of cell collection. Additional experiments with 
PE69 are required to test the validity of this preliminary conclusion. These experiments 











3 Effects of Aging-Delaying Plant Extracts on the Cellular Concentrations of 
Different Classes of Lipids 
 
3.1 Abstract 
The synthesis, storage and degradation of neutral lipids are integrated into 
metabolic pathways for other lipid classes. Therefore, the objective of studies described in 
this chapter of my thesis was to use a combination of liquid chromatography and mass 
spectrometry to examine how the aging-delaying plant extracts PE75 and PE77 influence 
the concentrations of several classes of lipids in yeast cells collected at different stages of 
chronological aging (i.e. on different days of cell collection). As I found in studies 
described in the previous chapter, both PE75 and PE77 increase the size of lipid droplets 
without affecting their number. My findings described in this chapter of the thesis indicate 
that PE75 and PE77 display different and statistically significant effects on the 
concentrations of phosphatidylinositol phospholipids, triacylglycerols and free fatty acids. 
Based on these findings, I infer that there may be two different ways of remodeling lipid 
metabolism in response to two different aging-delaying plant extracts. It remains to be seen 
whether any of these two ways of lipid metabolism remodeling may play a causal role in 
the delay of yeast chronological aging by these plant extracts. It will be also interesting to 
determine if any of these two ways of lipid metabolism remodeling may influence cellular 






3.2 Materials and Methods 
 
Yeast Strains, Growth Conditions 
The Saccharomyces cerevisiae wild-type strain BY4742 (MAT his31 leu20 
lys20 ura30) from Thermo Scientific/Open Biosystems was used. Grown in a synthetic 
minimal YNB medium (0.67% Yeast Nitrogen Base without amino acids) containing 2% 
(w/v) glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine 
and 20 mg/l uracil, with and without plant extracts. A 20% stock solution of each plant 
extract in ethanol was made on the day of cell inoculation into the growth medium at a 
final concentration of 0.1%, 0.3%, 0.5% and 1.0%. Cells were cultured at 30°C with 
rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask volume/medium volume” 
ratio of 5:1.  
 
Cell Collection for Liquid-Chromatography Mass Spectrometry 
 A total volume of yeast cell culture was calculated to obtain 5.0 × 107 cells/mL for 
each sample. These samples were then subjected to centrifugation at 3,000 × g for 5 min at 
room temperature. The pellet was washed with nanopure H2O and then washed with 155 
mM ammonium bicarbonate (pH 8.0). The final fractions were placed in 1.5-mL microfuge 
tubes and centrifuged at 20,000 × g for 1 min at room temperature. The pellet was then 






Chloroform:Methanol Lipid Extraction 
 Samples stored at -80°C were thawed on ice and then re-suspended in 400 µL of 
nanopure water. The samples were transferred to a 15-mL glass centrifuge tube containing 
approximately 400 µL of 425-600 µM acid-washed glass beads (Sigma Aldrich catalog 
#G8772), and 2 mL of chloroform:methanol at a 17:1 ratio (Fisher Scientific Catalog # 76-
09-3 and 67-56-1) was added. The samples were vortexed for 1 h and centrifuged at 3,000 
× g for 6 min. The lower organic phase was transferred to another glass centrifuge tube, 2 
mL of a chloroform:methanol at a 2:1 ratio was added to the remaining aqueous phase, 
which was further vortexed for 1 h and centrifuged at 3,000 × g for 6 min. The lower 
organic phase was combined with the previous organic phase and the solvent was 
evaporated through nitrogen gas.  
 
Sample Preparation for LC-MS 
 500 µL of acetonitrile:2-propanol:H2O (ratio of 65:35:5) (Fisher Scientific Catalog 
#s A9551, A4611 and W6212, all LC-MS grade) was added to the lipid film of each sample 
tube. Each sample was vortexed and sonicated for 15 min and vortexed once more before 




 These experiments were performed on an Agilent1100 series LC system (Agilent 
Technologies) equipped with a binary pump, de-gasser and auto-samples. Lipid species 
were separated on a reverse-phase column CSH C18 (2.1 mm; 75 mm; pore side 130Å; pH 
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range of 1-11) (Waters, Milford, MA) coupled to a CSH C18 VanGuard (Waters). The 
column was maintained at 55°C at a flow-rate of 0.3 mL/min. The mobile phases consisted 
on (A) 60:40 (v/v) acetonitrile:H2O and (B) 90:10 (v/v) isopropanol:acetonitrile. For the 
positive mode electrospray ionization (+) both mobile phases A and B were mixed with 10 
mM of ammonium formate (0.631 g/L) (Fisher Scientific Catalog # A115-50). For the 
negative mode electrospray ionization (-), both mobile phases were mixed with 10 mM 
ammonium acetate (0.771 g/L) (Fisher Scientific Catalog # 631-61-8). The separation of 
different lipid species by HPLC was achieved under the following HPLC gradient: 0 to 4 
min 90% (A); 4 to 10 min 40% (A); 10 to 21 min 32% (A); 21 to 24 min 3% (A); 24 to 33 
min 90% (A). A sample volume of 5 µL and 10 µL was used for the injection in ESI (+) 
and ESI (-) respectively. Samples were kept in the Agilent1100 well-plate.  
 
Mass Spectrometry 
 Extracted lipids that were initially separated by HPLC were then analyzed with the 
help of Thermo Orbitrap Velos Mass Spectrometer equipped with electrospray ionization 
(ESI) source (Thermo Scientific). Parent ions (MS-1) were detected in positive and 
negative modes using the FT analyzer at a resolution of 60,000. The MS-1 mass range was 
from 150-2000 Dalton. 
 
Table 3.1. Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings.  
Ion Source Type ESI 
Capillary Temperature (°C) 300 
Source Heater Temperature (°C) 300 
Sheath Gas Flow 10 




Table 3.2. Instrument method used for this experiment. HCD: High-energy-induced-
collision-dissociation. CID: Collision-induced-dissociation. 
Instrument Polarity Positive Negative 
Activation Type HCD CID 
Minimum Signal Required 5000 5000 




Default Charge State 2 2 
Activation Time 0.1 10 
 
LC-MS Data Processing 
 Raw files were analyzed by LipidSearch software (V4.1) from Thermo Fisher. This 
lipid identification software was used to identify different lipid classes with the help of the 
molecular fragmentation query language based on the parameters described in Table 3.3. 
In addition to the parameters outlined in Table 3.3, an extra manual filter was applied to 
eliminate any fatty acids containing an odd number of carbons and containing more than 
one double bond (polyunsaturated fatty acids).  
 
Table 3.3. The parameters for lipid search software (V4.1) used in this experiment. HCD: 
High-energy-induced-collision-dissociation. CID: Collision-induced-dissociation. 
Identification 
Database Orbitrap 
Peak detection Recall isotope (ON) 
Search option Product search Orbitrap 
Search type Product 
Experiment type LC-MS 
Precursor tol 10 ppm 
Product tol 
HCD (positive mode) 20 ppm 
CID (negative mode) 0.5 Da 
Quantitation 
Execute quantitation ON 
Mz tol -5.0; +5.0 
Tol type ppm 
Filter 
Top rank filter ON 
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Main node filter Main isomer peak 
m-score threshold 5.0 
c-score threshold 2.0 
FFA priority ON 
ID quality filter 
A 
Lipid class & FA are completely 
identified 
B 
Lipid class & some FA are 
identified 
C Lipid class or FA are identified 
D 
Lipid identified by other fragment 
ions (H2O and others) 
Lipid Class 
HCD (positive) PC, SO, TG 
CID (negative) CER, CL, FA, PE, PG, PI, PS 
Ions 
HCD (positive) +H, +NH4, +Na 




 Statistical analysis was preformed using Microsoft Excel’s (2017) Analysis 
ToolPack. All data are presented as mean  SD. The p values for comparing the means of 
two groups (using an unpaired t test) were calculated with the help of GraphPad Prism 













Previous unpublished studies have revealed that PE75 exhibits the highest 
efficiency of yeast chronological aging if used at the final concentration of 0.3% (w/v). I 
found that 0.3% PE75 statistically significantly increases the concentration of the 
phospholipid phosphatidylcholine in yeast cells collected on days 1, 3 and 4 of culturing 
(Figure 3.3.1). I also found that 0.3% PE75 statistically significantly decreases the 
concentration of phosphatidylcholine in yeast cells collected on day 2 of culturing (Figure 
3.3.1).   
 
Figure 3.3.1. 0.3% 
PE75 increases the 
concentration of 
phosphatidylcholine 
in yeast cells 
collected on days 1, 
3 and 4 of culturing, 
and decreases the 
concentration of 
phosphatidylcholine 
in yeast cells 
collected on day 2 of 
culturing.  WT cells 
were grown in YNB 
medium initially 
containing 2% 
glucose, in the 
presence of 0.3% 
PE75 or in its 
absence.  Cell 
aliquots were 
recovered on days 1, 2, 3 and 4 of culturing. Following extraction of lipids from cells recovered on different 
days of culturing, various lipid classes were identified and quantitated by a combination of liquid 
chromatography and tandem mass spectrometry. Based on these data, the relative concentration of 
phosphatidylcholine was calculated in mol% of all recovered and identified lipid classes. Data are presented 
as means ± SD (n = 2; *p < 0.05; **p < 0.01). 
 
I found that 0.3% PE75 statistically significantly increases the concentration of the 







contrast, 0.3% PE75 has no significant effect on the concentration of triacylglycerol in 





of the neutral 
lipid 
triacylglycerol 
in yeast cells 
collected on day 
1 of culturing 
but has no 
significant 




in yeast cells 
collected on 
days 2, 3 and 4 
of culturing.  
WT cells were 
grown in YNB medium initially containing 2% glucose, in the presence of 0.3% PE75 or in its absence.  Cell 
aliquots were recovered on days 1, 2, 3 and 4 of culturing. Following extraction of lipids from cells recovered 
on different days of culturing, various lipid classes were identified and quantitated by a combination of liquid 
chromatography and tandem mass spectrometry. Based on these data, the relative concentration of 
triacylglycerol was calculated in mol% of all recovered and identified lipid classes. Data are presented as 
means ± SD (n = 2; **p < 0.01; ns, not significant). 
 
 
I found that 0.3% PE75 has the following effects on the concentration of cardiolipin, 
a signature lipid of the mitochondrial inner membrane: 1) it statistically significantly 
decreases the concentration of cardiolipin in yeast cells collected on days 1 and 2 of 
culturing; 2) it has no significant effect on the concentration of cardiolipin in yeast cells 
collected on day 3 of culturing; and 3) it statistically significantly increases the 














collected on days 
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collected on day 






collected on day 4 of culturing.  WT cells were grown in YNB medium initially containing 2% glucose, in 
the presence of 0.3% PE75 or in its absence.  Cell aliquots were recovered on days 1, 2, 3 and 4 of culturing. 
Following extraction of lipids from cells recovered on different days of culturing, various lipid classes were 
identified and quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based 
on these data, the relative concentration of cardiolipin was calculated in mol% of all recovered and identified 
lipid classes. Data are presented as means ± SD (n = 2; *p < 0.05; **p < 0.01; ns, not significant). 
 
 
I found that 0.3% PE75 has the following effects on the concentration of the 
phospholipid phosphatidylethanolamine: 1) it statistically significantly decreases the 
concentration of phosphatidylethanolamine in yeast cells collected on days 1 and 3 of 
culturing; 2) it statistically significantly increases the concentration of 
phosphatidylethanolamine in yeast cells collected on day 3 of culturing; and 3) it has no 
significant effect on the concentration of phosphatidylethanolamine in yeast cells collected 




















collected on days 







collected on day 
3 of culturing 
and has no 
significant effect 
on the concentration of phosphatidylethanolamine in yeast cells collected on day 4 of culturing.  WT 
cells were grown in YNB medium initially containing 2% glucose, in the presence of 0.3% PE75 or in its 
absence.  Cell aliquots were recovered on days 1, 2, 3 and 4 of culturing. Following extraction of lipids from 
cells recovered on different days of culturing, various lipid classes were identified and quantitated by a 
combination of liquid chromatography and tandem mass spectrometry. Based on these data, the relative 
concentration of phosphatidylethanolamine was calculated in mol% of all recovered and identified lipid 
classes. Data are presented as means ± SD (n = 2; *p < 0.05; **p < 0.01; ns, not significant). 
 
 
I found that 0.3% PE75 statistically significantly increases the concentration of the 























inositol in yeast 
cells collected on 
each of the 4 
days of 
culturing.  WT 
cells were grown 
in YNB medium 
initially 
containing 2% 
glucose, in the 
presence of 0.3% 
PE75 or in its 
absence.  Cell 
aliquots were 
recovered on 
days 1, 2, 3 and 4 of culturing. Following extraction of lipids from cells recovered on different days of 
culturing, various lipid classes were identified and quantitated by a combination of liquid chromatography 
and tandem mass spectrometry. Based on these data, the relative concentration of phosphatidylinositol was 
calculated in mol% of all recovered and identified lipid classes. Data are presented as means ± SD (n = 2; *p 
< 0.05; **p < 0.01; ns, not significant). 
 
 
I found that 0.3% PE75 has the following effects on the concentration of 
sphingosine: 1) it statistically significantly increases the concentration of sphingosine in 
yeast cells collected on day 1 of culturing; 2) it statistically significantly decreases the 
concentration of sphingosine in yeast cells collected on day 3 of culturing; and 3) it has no 
significant effect on the concentration of sphingosine in yeast cells collected on days 2 and 






















collected on day 





collected on day 
3 of culturing 






collected on days 
2 and 4 of culturing.  WT cells were grown in YNB medium initially containing 2% glucose, in the presence 
of 0.3% PE75 or in its absence.  Cell aliquots were recovered on days 1, 2, 3 and 4 of culturing. Following 
extraction of lipids from cells recovered on different days of culturing, various lipid classes were identified 
and quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based on these 
data, the relative concentration of sphingosine was calculated in mol% of all recovered and identified lipid 
classes. Data are presented as means ± SD (n = 2; *p < 0.05; **p < 0.01; ns, not significant). 
 
I found that 0.3% PE75 has the following effects on the concentration of ceramide: 
1) it statistically significantly decreases the concentration of ceramide in yeast cells 
collected on day 2 of culturing; 2) it statistically significantly increases the concentration 
of ceramide in yeast cells collected on day 4 of culturing; and 3) it has no significant effect 


























collected on day 





collected on day 
4 of culturing 







days 1 and 3 of 
culturing.  WT cells were grown in YNB medium initially containing 2% glucose, in the presence of 0.3% 
PE75 or in its absence.  Cell aliquots were recovered on days 1, 2, 3 and 4 of culturing. Following extraction 
of lipids from cells recovered on different days of culturing, various lipid classes were identified and 
quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based on these data, 
the relative concentration of ceramide was calculated in mol% of all recovered and identified lipid classes. 
Data are presented as means ± SD (n = 2; *p < 0.05; ns, not significant). 
 
 
I found that 0.3% PE75 has the following effects on the concentration of free fatty 
acids: 1) it statistically significantly decreases the concentration of free fatty acids in yeast 
cells collected on days 1, 3 and 4 of culturing; and 2) it has no significant effect on the 

























free fatty acids 
in yeast cells 
collected on days 






free fatty acids 
in yeast cells 
collected on day 
2 of culturing.  
WT cells were 
grown in YNB 
medium initially 
containing 2% 
glucose, in the 
presence of 0.3% PE75 or in its absence.  Cell aliquots were recovered on days 1, 2, 3 and 4 of culturing. 
Following extraction of lipids from cells recovered on different days of culturing, various lipid classes were 
identified and quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based 
on these data, the relative concentration of free fatty acids was calculated in mol% of all recovered and 




Previous unpublished studies have revealed that PE77 exhibits the highest 
efficiency of yeast chronological aging if used at the final concentration of 0.5% (w/v). I 
found that 0.5% PE77 statistically significantly increases the concentration of the 
phospholipid phosphatidylcholine in yeast cells collected on day 1 of culturing (Figure 
3.3.9). I also found that 0.5% PE77 has no significant effect on the concentration of 













Figure 3.3.9. 0.5% PE77 
increases the 
concentration of the 
phospholipid 
phosphatidyl-choline in 
yeast cells collected on 
day 1 of culturing and 
has no significant effect 
on the concentration of 
phosphatidyl-choline in 
yeast cells collected on 
days 2, 3 and 4 of 
culturing.  WT cells were 
grown in YNB medium 
initially containing 2% 
glucose, in the presence 
of 0.5% PE77 or in its 
absence.  Cell aliquots 
were recovered on days 1, 
2, 3 and 4 of culturing. 
Following extraction of lipids from cells recovered on different days of culturing, various lipid classes were 
identified and quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based 
on these data, the relative concentration of phosphatidylcholine was calculated in mol% of all recovered and 
identified lipid classes. Data are presented as means ± SD (n = 2; **p < 0.01; ns, not significant). 
 
I found that 0.5% PE77 statistically significantly decreases the concentration of 
triacylglycerol in yeast cells collected on each of the 4 days of culturing (Figure 3.3.10). 
Figure 3.3.10. 0.5% 
PE77 decreases the 
concentration of 
triacylglycerol in yeast 
cells collected on each of 
the 4 days of culturing.  
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE77 or in its absence.  
Cell aliquots were 
recovered on days 1, 2, 3 
and 4 of culturing. 
Following extraction of 
lipids from cells 
recovered on different 
days of culturing, various 
lipid classes were 
identified and quantitated 
by a combination of liquid chromatography and tandem mass spectrometry. Based on these data, the relative 
concentration of triacylglycerol was calculated in mol% of all recovered and identified lipid classes. Data are 












I found that 0.5% PE77 has the following effects on the concentration of cardiolipin, 
a signature lipid of the mitochondrial membranes: 1) it statistically significantly decreases 
the concentration of cardiolipin in yeast cells collected on day 3 of culturing; and 2) it has 
no significant effect on the concentration of cardiolipin in yeast cells collected on days 1, 
2 and 4 of culturing (Figure 3.3.11). 
 
Figure 3.3.11. 0.5% 
PE77 decreases the 
concentration of 
cardiolipin in yeast 
cells collected on 
day 3 of culturing 
and has no 
significant effect on 
the concentration 
of cardiolipin in 
yeast cells collected 
on days 1, 2 and 4 
of culturing.  WT 
cells were grown in 
YNB medium 
initially containing 
2% glucose, in the 
presence of 0.5% 
PE77 or in its 
absence.  Cell 
aliquots were 
recovered on days 1, 2, 3 and 4 of culturing. Following extraction of lipids from cells recovered on different 
days of culturing, various lipid classes were identified and quantitated by a combination of liquid 
chromatography and tandem mass spectrometry. Based on these data, the relative concentration of cardiolipin 
was calculated in mol% of all recovered and identified lipid classes. Data are presented as means ± SD (n = 
2; *p < 0.05; ns, not significant). 
 
I found that 0.5% PE77 statistically significantly increases the concentration of the 
phospholipid phosphatidylethanolamine in yeast cells collected on each of the 4 days of 












Figure 3.3.12. 0.5% 
PE77 increases the 
concentration of the   
phospholipid 
phosphatidyl-
ethanolamine in yeast 
cells collected on each of 
the 4 days of culturing.  
WT cells were grown in 
YNB medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE77 or in its absence.  
Cell aliquots were 
recovered on days 1, 2, 3 
and 4 of culturing. 
Following extraction of 
lipids from cells 
recovered on different 
days of culturing, various 
lipid classes were identified and quantitated by a combination of liquid chromatography and tandem mass 
spectrometry. Based on these data, the relative concentration of phosphatidylethanolamine was calculated in 
mol% of all recovered and identified lipid classes. Data are presented as means ± SD (n = 2; *p < 0.05; **p 
< 0.01; ***p < 0.001). 
 
I found that 0.5% PE77 statistically significantly decreases the concentration of the 
phospholipid phosphatidylinositol in yeast cells collected on each of the 4 days of culturing 
(Figure 3.3.13). 
Figure 3.3.13. 0.5% 
PE77 decreases the 
concentration of the   
phospholipid 
phosphatidyl-inositol in 
yeast cells collected on 
each of the 4 days of 
culturing.  WT cells were 
grown in YNB medium 
initially containing 2% 
glucose, in the presence 
of 0.5% PE77 or in its 
absence.  Cell aliquots 
were recovered on days 1, 
2, 3 and 4 of culturing. 
Following extraction of 
lipids from cells 
recovered on different 
days of culturing, various 
lipid classes were 
identified and quantitated by a combination of liquid chromatography and tandem mass spectrometry. Based 
on these data, the relative concentration of phosphatidylinositol was calculated in mol% of all recovered and 













I found that 0.5% PE77 has no significant effect on the concentration of sphingosine 
in yeast cells collected on each of the 4 days of culturing (Figure 3.3.14). 
 
Figure 3.3.14. 0.5% 
PE77 has no 
significant effect on 
the concentration 
of sphingosine in 
yeast cells collected 
on each of the 4 
days of culturing.  
WT cells were 
grown in YNB 
medium initially 
containing 2% 
glucose, in the 
presence of 0.5% 
PE77 or in its 
absence.  Cell 
aliquots were 
recovered on days 1, 
2, 3 and 4 of 
culturing. Following 
extraction of lipids 
from cells recovered on different days of culturing, various lipid classes were identified and quantitated by a 
combination of liquid chromatography and tandem mass spectrometry. Based on these data, the relative 
concentration of sphingosine was calculated in mol% of all recovered and identified lipid classes. Data are 
presented as means ± SD (n = 2; ns, not significant). 
 
 
I found that 0.5% PE77 statistically significantly increases the concentration of 
ceramide in yeast cells collected on day 1 of culturing and has no significant effect on the 

















Figure 3.3.15. 0.5% 
PE77 increases the 
concentration of 
ceramide in yeast cells 
collected on day 1 of 
culturing and has no 
significant effect on the 
concentration of 
ceramide in yeast cells 
collected on days 2, 3 
and 4 of culturing.  WT 
cells were grown in YNB 
medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE77 or in its absence.  
Cell aliquots were 
recovered on days 1, 2, 3 
and 4 of culturing. 
Following extraction of 
lipids from cells recovered on different days of culturing, various lipid classes were identified and quantitated 
by a combination of liquid chromatography and tandem mass spectrometry. Based on these data, the relative 
concentration of ceramide was calculated in mol% of all recovered and identified lipid classes. Data are 
presented as means ± SD (n = 2; **p < 0.01; ns, not significant). 
 
I found that 0.5% PE77 statistically significantly increases the concentration of free 
fatty acids in yeast cells collected on each of the 4 days of culturing (Figure 3.3.16). 
Figure 3.3.16. 0.5% 
PE77 increases the 
concentration of free 
fatty acids in yeast cells 
collected on each of the 
4 days of culturing.  WT 
cells were grown in YNB 
medium initially 
containing 2% glucose, in 
the presence of 0.5% 
PE77 or in its absence.  
Cell aliquots were 
recovered on days 1, 2, 3 
and 4 of culturing. 
Following extraction of 
lipids from cells 
recovered on different 
days of culturing, various 
lipid classes were 
identified and quantitated 
by a combination of liquid chromatography and tandem mass spectrometry. Based on these data, the relative 
concentration of free fatty acids was calculated in mol% of all recovered and identified lipid classes. Data 









My mass spectrometry-based analysis of how the aging-delaying plant extracts 
PE75 and PE77 influence the concentrations of different classes of lipids in chronologically 
aging yeast revealed that each of them remodels lipid metabolism in a different way. 
Because PE77 alters the concentrations of several lipid classes through the entire process 
of chronological aging (see Figures 3.3.9 – 3.3.16), I will first discuss this PE77-dependent 
way of lipid metabolism remodeling. As schematically depicted in Figure 3.4.1, PE77 
exhibit the following effects on the concentrations of lipids: 1) it increases the 
concentrations of phosphatidylethanolamine (PE) and free fatty acids (FFA); and 2) it 
decreases the concentrations of triacylglycerols (TAG) and phosphatidylinositol (PI). The 
metabolism of these lipid classes is known to take place in the ER, lipid droplets (LD) and 
mitochondria, which establish the so-called contact sites for the interorganellar transport 
of some lipid classes (Kohlwein et al., 2013; Mitrofanova et al., 2018) (Figures 3.4.1 and 
3.4.2). Based on the observed pattern of changes in lipid concentrations, I suggest the 
following hypothetical mechanism for the PE77-dependent remodeling of lipid 
metabolism; 1) the rise in the concentration of PE may be due to an acceleration in PE 
synthesis within the inner mitochondrial membrane (IMM) and/or an acceleration of PE 
transport from the IMM to the ER membrane; 2) both the increase in the concentration of 
FFA and the decrease in the concentration of TAG may be caused by an acceleration of the 
ER-to-LD transfer of TAG and/or by an acceleration of the lipolytic degradation of TAG 
into FFA taken place within LD; and 3) the decline in the concentration of PI may be due 
to a deceleration of the conversion of phosphatidic acid (PA) into PI (Figure 3.4.1). The 
existence of this hypothetical mechanism for the PE77-dependent remodeling of lipid 
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metabolism will be tested in the future by measuring the rates of metabolic and transport 
reactions involved in lipid metabolism and transport within the ER, LD and mitochondria 
(Figure 3.4.2).    
Figure 3.4.1. A hypothetical 
mechanism for the PE77-
dependent remodeling of 
lipid metabolism in 
chronologically aging yeast. 
The thickness of black arrows 
is proportional to the rates of 
the corresponding metabolic 
reactions. Arrows next to the 
names of lipid classes denote 
those of them whose 
concentrations are increased 
(red arrows) or decreased 
(blue arrows) in yeast treated 
with PE77. See text for more 
details. Abbreviations: ER, 
the endoplasmic reticulum; 
FFA, free fatty acids; IMM, the inner mitochondrial membrane; LD, lipid droplet; OMM, the outer 
mitochondrial membrane; PE, phosphatidylethanolamine; PI, phosphatidylinositol; TAG, triacylglycerols. 
 
Figure 3.4.2. Lipid 
metabolism and 
interorganellar 
transport in the ER, LD 
and mitochondria of 







It remains to be seen whether this PE77-dependent way of lipid metabolism 
remodeling may play a causal role in the delay of yeast chronological aging by PE77. This 
important question will be addressed in the future by examining how single-gene-deletion 
mutations that eliminate redundant enzymes involved in different reactions of lipid 
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metabolism and interorganellar transport influence the efficiency with which PE77 delays 
yeast chronological aging. Although it is known that most of these mutations alter the 
concentrations of the substrates and products of the reactions affected by the mutations 
(Kohlwein et al., 2013; Mitrofanova et al., 2018), it will be important to measure the 
concentrations of different lipid classes in the future experiments addressing a causal 
relationship between the PE77-dependent lipid metabolism remodeling and the PE77-
dependent delay of yeast chronological aging.         
All lipid classes whose concentrations are changed in response to exposure of yeast 
to PE77 play essential roles in such longevity-defining cellular processes as signal 
transduction, vesicular transport of proteins and stress response (Kohlwein et al., 2013; 
Mitrofanova et al., 2018). Therefore, as a first step towards addressing the mechanism(s) 
through which the PE77-dependent remodeling of lipid metabolism may delay yeast 
chronological aging, it will be important in the future to examine how an exposure of yeast 
cell to PE77 can influence cellular signaling, vesicular protein trafficking, stress response.     
My findings on mass spectrometry-based lipid quantitation indicate that that PE75 
remodels metabolism in a different way than PE77. Because PE75 alters the concentrations 
of several lipid classes differently during different phases of the process of chronological 
aging (see Figures 3.3.1 – 3.3.8), it is a challenge to understand how such diverse 
alterations may lead to a delay of yeast chronological aging. PE75 exhibit the following 
effects on the concentrations of lipids: 1) it increases the concentrations of PI during all 
stages of the process of chronological aging; 2) it decreases the concentration of FFA on 3 
out of 4 days of cell collection; 3) it increases the concentration of phosphatidylcholine 
(PC) on 3 out of 4 days of cell collection (Figures 3.3.1 – 3.3.8). The experimental strategy 
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that has been describe above for PE77 can be also used in the future to test if this PE75-
dependent way of lipid metabolism remodeling may play a causal role in the delay of yeast 
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